Company Financials

Ryman Healthcare Ltd Financials

Euro

business Ryman Healthcare Ltd Company Profile

Main Stock Listing

FSX: RH7

Market Capitalization €1.49 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 9.35
Forward PE
Price to Sales TTM €1.85
Price to Book MRQ €0.69
Enterprise to Revenue 3.86
Enterprise to EBITDA 79.14

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2025-03-31
Most Recent Quarter 2025-03-31
Profit Margin -69.85%
Operating Margin 3.56%
Return on Assets TTM 0.04%
Return on Equity TTM -13.37%

Income Statement

Revenue TTM €397,304,888
Revenue per Share TTM €0.92
Quarterly Revenue Growth 13.20%
Gross Profit TTM €26,011,657
EBITDA €71,731,085
Net Income to Common TTM €-277,518,208
Diluted EPS TTM €-0.31
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ €4,607,860
Total Cash per Share MRQ €0.01
Total Debt MRQ
Total Debt to Equity MRQ 41.02
Current Ratio MRQ 0.03
Book Value per Share MRQ €2.01

Cash Flow

Operating Cash Flow TTM €158,461,701
Levered Free Cash Flow TTM €154,897,200

RH7 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 1,015,713,000
Float Shares 986,930,225
Avg 10 Volume 4,932
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 14.08%
% Held by Institutions 25.62%

Stock Price Summary

Beta 0.28
Fifty Two Week Low €1.04
Fifty Two Week High €2.54
Fifty Two Week Change -81.25%
Day 50 MA €1.37
Day 200 MA €1.26

Dividends and Splits

Forward Annual Dividend Rate €0.08
Forward Annual Dividend Yield 5.54%
Trailing Annual Dividend Rate €0.10
Trailing Annual Dividend Yield 7.05%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2022-12-08
Last Split Factor
Last Split Date